Showing 5121-5130 of 8655 results for "".
- Aesthetic Innovations Summit Coming to New Orleanshttps://practicaldermatology.com/news/aesthetic-innovations-summit-coming-to-new-orleans/2460022/Coming off an impressive inaugural meeting in 2018, the second annual Aesthetics Innovation Summit will unite over 300 of the most influential corporate, capital, and clinical leaders in New Orleans to collaborate on the development and adoption of new aesthetic treatments and technologies.
- Kamedis: Clinical Study Validates Traditional Chinese Botanical for Eczemahttps://practicaldermatology.com/news/kamedis-clinical-study-validates-traditional-chinese-botanical-for-eczema/2460020/Traditional Chinese botanicals in homeopathic over-the-counter Kamedis Calm Eczema Therapy Cream play a pivotal role in the product’s ability to reduce eczema rashes, according to results of a new study announced by the company. Results show that commer
- Crown Labs Adds to Portfolio with Acquisition of Keri from GSKhttps://practicaldermatology.com/news/crown-labs-adds-to-portfolio-with-acquisition-of-keri-from-gsk/2460017/Crown Laboratories, Inc. acquired the North American rights for Keri from GlaxoSmithKline (GSK). The acquisition of Keri from GSK marks the sixth product from GSK that Crown has acquired in the past five months. “Acqui
- ISHRS Awareness Campaign Takes on Black Market Hair Restoration Clinicshttps://practicaldermatology.com/news/ishrs-awareness-campaign-takes-on-black-market-hair-restoration-clinics/2460016/The International Society of Hair Restoration Surgery (ISHRS) is launching a new public awareness campaign to help patients recognize “black market pirate” hair restoration clinics and misleading advertising claims. Social media engagement will be the cornerstone of the new
- Xstrahl Introduces UpGraded Treatment System for Non-Melanoma Skin Cancerhttps://practicaldermatology.com/news/xstrahl-introduces-upgraded-treatment-system-for-non-melanoma-skin-cancer/2460011/Xstrahl Medical is launching its latest superficial radiotherapy treatment system to treat the full range of non-melanoma skin cancer cases. The new Xstrahl 150 system offers several features that enhance the capabilities of Xstrahl's curr
- Brooke Shields Takes on New Role as Celebrity Spokesperson for SculpSure Body Contouringhttps://practicaldermatology.com/news/brooke-shields-take-on-new-role-as-celebrity-spokesperson-for-sculpsure-body-contouring/2460005/Actress, model, Broadway star, and author Brooke Shields will serve as national spokesperson for Hologic’s Cynosure's SculpSure body contouring laser treatment. As the face of SculpSure’s new “Be strong. Be sexy. Be confident.” campaign, Ms. Shields will inspire consum
- Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapyhttps://practicaldermatology.com/news/fibrocell-to-collaborate-with-castle-creek-pharmaceuticals-to-develop-and-commercialize-rdeb-gene-therapy/2460004/Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB), a rare, life-threatening genetic disord
- L'Oreal To Support Reconstruction of Notre Dame Cathedralhttps://practicaldermatology.com/news/loreal-to-support-reconstruction-of-notre-dame-cathedral/2460003/The Bettencourt Meyers family and the L’Oréal Group are making a joint donation of 100 million euros toward the “renaissance” of the Notre-Dame Cathedral, which they describe as a symbol of French heritage and common history.
- Industry Vet Linda Esposito Named New CFO at Skyn ICELANDhttps://practicaldermatology.com/news/industry-vet-linda-esposito-named-new-cfo-at-skyn-iceland/2460002/Linda Esposito is the new Chief Financial Officer at Skyn ICELAND, a privately held New York-based skin care company. Ms. Esposito will report to Founder and Chief Executive Officer Sarah Kugelman and will oversee all financial aspects of t
- A Conserved Stress Response May Fuel Resistance to BRAF Inhibitors in Melanomahttps://practicaldermatology.com/news/a-conserved-stress-response-may-fuel-resistance-to-braf-inhibitors-in-melanoma/2459999/Moffitt Cancer